• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

《不同中国人群对新冠病毒变异株的全面体液免疫和细胞免疫反应》勘误

Corrigendum to "Comprehensive Humoral and Cellular Immune Responses to SARS-CoV-2 Variants in Diverse Chinese Population".

作者信息

Li Jiwei, Wu Jing, Long Qiuyue, Wu Yan'an, Hu Xiaoyi, He Yukun, Jiang Mingzheng, Li Jia, Zhao Lili, Yang Shuoqi, Chen Xiaoyong, Wang Minghui, Zheng Jianshi, Wu Fangfang, Wu Ruiliang, Ren Lihong, Bu Liang, Wang Houzhao, Li Ke, Fu Lijuan, Zhang Guojun, Zheng Yali, Gao Zhancheng

机构信息

Department of Respiratory, Critical Care and Sleep Medicine, Xiang'an Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China.

School of Medicine, Xiamen University, Xiamen, Fujian, China.

出版信息

Research (Wash D C). 2022 Nov 14;2022:9796409. doi: 10.34133/2022/9796409. eCollection 2022.

DOI:10.34133/2022/9796409
PMID:36474604
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9703914/
Abstract

[This corrects the article DOI: 10.34133/2022/9873831.].

摘要

[本文更正了文章的数字对象标识符：10.34133/2022/9873831。]

相似文献

1
Corrigendum to "Comprehensive Humoral and Cellular Immune Responses to SARS-CoV-2 Variants in Diverse Chinese Population".《不同中国人群对新冠病毒变异株的全面体液免疫和细胞免疫反应》勘误
Research (Wash D C). 2022 Nov 14;2022:9796409. doi: 10.34133/2022/9796409. eCollection 2022.
2
Humoral, Cellular and Cytokine Immune Responses Against SARS-CoV-2 Variants in COVID-19 Convalescent and Confirmed Patients With Different Disease Severities.体液、细胞和细胞因子免疫应答对 COVID-19 恢复期和确诊患者不同疾病严重程度的 SARS-CoV-2 变异株的反应。
Front Cell Infect Microbiol. 2022 May 17;12:862656. doi: 10.3389/fcimb.2022.862656. eCollection 2022.
3
Corrigendum: Brief Research Report: Virus-Specific Humoral Immunity at Admission Predicts the Development of Respiratory Failure in Unvaccinated SARS-CoV-2 Patients.勘误：简短研究报告：未接种疫苗的新冠病毒患者入院时的病毒特异性体液免疫可预测呼吸衰竭的发生
Front Immunol. 2022 Jun 30;13:965809. doi: 10.3389/fimmu.2022.965809. eCollection 2022.
4
Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting.在真实环境中评估灭活 COVID-19 疫苗诱导的 SARS-CoV-2 特异性体液和细胞免疫应答的特征。
Front Immunol. 2021 Dec 22;12:802858. doi: 10.3389/fimmu.2021.802858. eCollection 2021.
5
Corrigendum to "The Cumulative Rate of SARS-CoV-2 Infection in Chinese Hemodialysis Patients" [Kidney Int. Rep. 2020 1416-1421].《中国血液透析患者中 SARS-CoV-2 感染的累积率》[《肾脏国际报告》2020 年第 1416 - 1421 页]勘误
Kidney Int Rep. 2021 Sep;6(9):2525. doi: 10.1016/j.ekir.2021.07.021. Epub 2021 Sep 2.
6
Development of Potent Cellular and Humoral Immune Responses in Long-Term Hemodialysis Patients After 1273-mRNA SARS-CoV-2 Vaccination.1273-mRNA 新冠病毒疫苗接种后长期血液透析患者中产生强烈细胞和体液免疫应答。
Front Immunol. 2022 Mar 23;13:845882. doi: 10.3389/fimmu.2022.845882. eCollection 2022.
7
Humoral and cellular immune responses to SARS CoV-2 vaccination in People with Multiple Sclerosis and NMOSD patients receiving immunomodulatory treatments.体液和细胞免疫对接受免疫调节治疗的多发性硬化症和 NMOSD 患者的 SARS-CoV-2 疫苗接种的反应。
Mult Scler Relat Disord. 2022 Mar;59:103554. doi: 10.1016/j.msard.2022.103554. Epub 2022 Jan 22.
8
Impact of disease-modifying therapies on humoral and cellular immune-responses following SARS-CoV-2 vaccination in MS patients.疾病修正疗法对 MS 患者 COVID-19 疫苗接种后体液和细胞免疫反应的影响。
Clin Transl Sci. 2022 Jul;15(7):1606-1612. doi: 10.1111/cts.13256. Epub 2022 Mar 4.
9
Corrigendum: SARS-CoV-2: Emergence of New Variants and Effectiveness of Vaccines.勘误：严重急性呼吸综合征冠状病毒2：新变种的出现及疫苗的有效性。
Front Cell Infect Microbiol. 2022 Jun 1;12:885482. doi: 10.3389/fcimb.2022.885482. eCollection 2022.
10
Dynamics of humoral and cellular immune responses after homologous and heterologous SARS-CoV-2 vaccination with ChAdOx1 nCoV-19 and BNT162b2.同源和异源 SARS-CoV-2 疫苗接种（ChAdOx1 nCoV-19 和 BNT162b2）后体液和细胞免疫反应的动力学。
EBioMedicine. 2022 Nov;85:104294. doi: 10.1016/j.ebiom.2022.104294. Epub 2022 Oct 4.

引用本文的文献

1
Vascularized organoid-on-a-chip: design, imaging, and analysis.血管化类器官芯片：设计、成像和分析。
Angiogenesis. 2024 May;27(2):147-172. doi: 10.1007/s10456-024-09905-z. Epub 2024 Feb 26.
2
Construction of an abnormal glycosylation risk model and its application in predicting the prognosis of patients with head and neck cancer.构建异常糖基化风险模型及其在预测头颈部癌症患者预后中的应用。
Sci Rep. 2024 Jan 15;14(1):1310. doi: 10.1038/s41598-023-50092-6.

本文引用的文献

1
Comprehensive Humoral and Cellular Immune Responses to SARS-CoV-2 Variants in Diverse Chinese Population.中国不同人群对新冠病毒变异株的全面体液免疫和细胞免疫反应
Research (Wash D C). 2022 Jun 16;2022:9873831. doi: 10.34133/2022/9873831. eCollection 2022.